Interferencias electromagnéticas en pacientes con marcapasos y cardiodesfibriladores implantados

  • Pablo Fernández Banizi CASMU-INCC, Servicio de Electrofisiología y Arritmias (SEA)
  • Luis Vidal CASMU-INCC, Servicio de Electrofisiología y Arritmias (SEA)
  • José Luis Montenegro CASMU-INCC, Servicio de Electrofisiología y Arritmias (SEA)
  • Daniel Banina Aguerre CASMU-INCC, Servicio de Electrofisiología y Arritmias (SEA)
  • Gabriel Vanerio CASMU-INCC, Servicio de Electrofisiología y Arritmias (SEA)
  • Serrana Antunes CASMU-INCC, Servicio de Electrofisiología y Arritmias (SEA)
  • Daniel Fiandra Instituto Nacional de Cirugía Cardíaca (INCC), Equipo de Marcapasos
  • Héctor Alfredo Fiandra Instituto Nacional de Cirugía Cardíaca (INCC), Equipo de Marcapasos
  • Diego Lupano Instituto Nacional de Cirugía Cardíaca (INCC), Equipo de Marcapasos
  • Orestes Fiandra Instituto Nacional de Cirugía Cardíaca (INCC), Equipo de Marcapasos
Palabras clave: DEFIBRILADORES IMPLANTABLES, MARCAPASO ARTIFICIAL, RADIACIÓN

Resumen

Hemos efectuado una revisión de las probables interferencias electromagnéticas en aquellos pacientes portadores de marcapasos cardíacos (MP) o cardiodesfibriladores automáticos implantables (DAI), o ambos, tanto en la vida diaria como en el ambiente laboral, y también cuando son sometidos a una serie de exámenes y procedimientos terapéuticos en un ambiente médico. Dada la gran cantidad de señales electromagnéticas que nos rodean, los probables problemas son mínimos, pudiéndose aun disminuirlos en un mayor rango con una correcta educación del paciente y de los médicos no habituados al manejo de pacientes portadores de estos sistemas. Un trabajo en conjunto, con pautas claras, entre los cardiólogos electrofisiólogos o marcapasistas y los demás colegas de disciplinas diferentes, redundaría en un beneficio para el paciente, disminuyendo al mínimo los problemas que las interferencias electromagnéticas puedan causar en estos pacientes.

Citas

1) Irnich W. Interference in pacemakers. Pacing Clin Electrophysiol 1984; 7(6 Pt 1): 1021-48.
2) Olson WII. The effects of external interference on ICDs and PMs. In: Estes III NA, Manolis AS, Wang PJ, eds. Implantable cardioverter defibrillators: a comprehensive textbook. New York: Marcel Dekker, 1994: 139-52.
3) Jones GK, Bardy GH. Considerations for ventricular fibrillation detection by implantable cardioverter defibrillators. Am Heart J 1994; 127(4 Pt 2): 1107-10.
4) Brumwell DA, Kroll K, Lehmann MH. The amplifier: Sensing the depolaritation. In: Kroll MW, Lehmann MH, eds. Implantable cardioverter defibrillator therapy: the engineering/clinical interface. Massachusetts: Kluwer Academical Publisher, 1996: 275-302.
5) Chew EW, Troughear RH, Kuchar DL, Thorburn CW. Inappropiate rate change in minute ventilation rate responsive pacemakers due to interference by cardiac monitor. Pacing Clin Electrtophysiol 1997; 20(2 Pt 1): 276-82.
6) Southorn PA, Kamath GS, Vasdev GM, Hayes DL. Monitoring equipment induced tachycardia in patients with minute ventilation rate re-responsive pacemakers. Br J Anaesth 2000; 84(4): 508-9.
7) McIvor ME, Reddinger J, Floden E, Sheppard RC. Study of pacemaker and implantable cardioverter defibrillator triggering by electronic article surveillance devices (SPICED TEAS) Pacing Clin Electrtophysiol 1998; 21(10): 1847-61.
8) Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995; 92(6): 1651-64.
9) Kolb C, Zrenner B, Schmitt C. Incidence of electromagnetic interference in implantable cardioverter defibrillator. Pacing Clin Electrtophysiol 2001; 24(4 Pt 1): 465-8.
10) Mann DE, Kelly PA, Reiter MJ. Inappropriate shock therapy for nonsustained ventricular tachycardia in a dual chamber pacemaker defibrillator. Pacing Clin Electrophysiol 1998; 21(10): 2005-6.
11) Strathmore NF. Interference in cardiac pacemakers. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical cardiac pacing. Philadelphia: WB Saunders, 1995: 770-9.
12) Glikson M, Trusty JM, Grice SK, Hayes DL, Hammill SC, Stanton MS. Importance of pacemakers noise reversion as a potential mechanism of pacemakers-ICD interactions. Pacing Clin Electrophysiol 1998; 21(5): 1111-21.
13) Bilitch M, Cosby RS, Cafferky EA. Ventricular fibrillation and competitive pacing. N Engl J Med 1967; 276(11): 598-604.
14) van Lake P , Mattioni T. The effect therapeutic magnet on implantable pacemaker and defibrillator devices. Pacing Clin Electrophysiol 2000; 23: 723. (Abstract)
15) Toivonen L, Valjus J, Hongisto m, Metso R. The influence of elevated 50 Hz electric and magnetic fields on implanted cardiac pacemakers: the role of the lead configuration and programming of the sensitivity. Pacing Clin Electrophysiol 1991; 14(12): 2114-22.
16) Gunderson BD, Pratt T, Johonson WB, et al. Ventriccular oversensing in ICD patients: True bipolar vs integrated bipolar sensing. Pacing Clin Electrophysiol 2001; 24: 560. (Abstract).
17) Yesil M, Bayata S, Postaci N, Aydin C. Pacemaker inhibition and asystole in a pacemaker dependent patient. Pacing Clin Electrtophysiol 1995; 18(10): 1963.
18) Irnich W, Batz L, Muller R, Tobisch R. Electromagnetic interference of pacemakers by mobile phones. Pacing Clin Electrtrophysiol 1996; 19(10): 1431-46.
19) Ruggera PS, Witters DM, Bassen HI. In vitro testing of pacemakers for digital cellular phone electromagnetic interference. Biomed Instrum Technol 1997; 31(4): 358-71.
20) Tan KS, Hinberg I. Can wireless communication systems affect implantable cardiac pacemakers? An in vitro laboratory study. Biomed Instrum Technol 1998; 32(1): 18-24.
21) Schlegel RE, Grant FH, Raman S, Reynolds D. Electromagnetic compatibility study of the in-vitro interaction of wireless phones with cardiac pacemakers. Biomed Instrum Technol 1998; 32(6): 645-55.
22) Hayes DL, Wang PJ, Reynolds DW, Estes M 3rd, Griffith JL, Steffens RA, et al. Interference with cardiac pacemakers by cellular telephones. N Engl J Med 1997; 336(21): 1473-9.
23) Naegeli B, Osswald S, Deola M, Burkart F. Intermittent pacemaker dysfunction caused by digital mobile telephones. J Am Coll Cardiol 1996; 27(6): 1471-7.
24) Sparks PB, Mond HG, Joyner KH, Wood MP. The safety of digital mobile cellular telephones with minute ventilation rate adaptive pacemakers. Pacing Clin Electrophysiol 1996; 19(10): 1451-5.
25) Bassen HI, Moore HJ, Ruggera PS. Cellular phone interference testing of implantable cardiac defibrillators in vitro. Pacing Clin Electrophysiol 1998; 21(9): 1709-15.
26) Jiménez A, Hernández Madrid A, Pascual J, González Rebollo JM, Fernández E, Sánchez A, et al. Interferencias electromagnéticas entre los desfibriladores automáticos y los teléfonos móviles digitales y análogos. Rev Esp Cardiol 1998; 51(5): 375-82.
27) Fetter JG, Ivans V, Benditt DG, Collins J. Digital cellular telephone interaction with implantable cardioverter-defibrillators. J Am Coll Cardiol 1998; 31(3): 623-8.
28) Sanmartín M, Fernández Lozano I, Márquez J, Antorrena I, Bautista A, Silva L, et al. Ausencia de interferencia entre los teléfonos móviles GSM y los desfibriladores implantables: estudio in-vivo. Rev Esp Cardiol 1997; 50(10): 715-9.
29) Chiladakis JA, Davlouros P, Agelopoulos G, Manolis AS. In-vivo testing of digital cellular telephones in patients with implantable cardioverter-defibrillator. Eur Heart J 2001; 22(15): 1337-42.
30) Occhetta E, Plebani L, Bortnick M, Sacchetti G, Trevi G. Implantable cardioverter-difibrillators and cellular telephones: is there any interference? Pacing Clin Electrtophysiol 1999; 22(7): 983-9.
31) Stanton MS, Grice SE, Trusty J, et al. Safety of various cellular phone technologies with implantable cardioverter-defibrillators. Pacing Clin Electrrophysiol 1996; 19: 583. (Abstract).
32) McIvor ME. Environmental electromagnetic interference from electronic article surveillance devices: interactions with an ICD. Pacing Clin Electrophysiol 1995; 18(12 Pt 1): 2229-30.
33) Mathew P, Lewis C, Neglia J, Krol RB, Saksena S. Interaction between electronic article surveillance systems and implantable defibrillators: insights from a fourth generation ICD. Pacing Clin Electrophysiol 1997; 20(11): 2857-9.
34) Harthorne JW. Theft deterrent systems: a threat for medical device recipients or an industry cat fight?Pacing Clin Electrophysiol 1998; 21(10): 1845-6.
35) Tan KS, Hinberg I. Can electronic article surveillance systems affect implantable cardiac pacemakers and defibrillators? Pacing Clin Electrrophysiol 1998; 21: 960. (Abstract)
36) Dodinot B, Godenir JP, Costa AB. Electronic article surveillance: a possible danger for pacemaker patients. Pacing Clin Electrophysiol 1993; 16(1 Pt 1): 46-53.
37) Mugica J, Henry L, Podeur H. Study of interactions between permanent pacemakers and electronic antitheft surveillance systems. Pacing Clin Electrtophysiol 2000; 23(3): 333-7.
38) Santucci PA, Haw J, Trohman RG, Pinski SL. Interference with an implantable defibrillator by an electronic antitheft-surveillance device. N Engl J Med 1998; 339(19): 1371-4.
39) Groh WJ, Boschee SA, Engelstein ED, Miles WM, Burton ME, Foster PR, et al. Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators. Circulation 1999; 100(4): 387-92.
40) Moss CE. Case studies: exposure to electromagnetic fields while operating walk-through and hand-held metal detectors. Appl Occup Environ Hyg 1998; 13(7): 501-4.
41) Copperman Y, Zarfati D, Laniado S. The effect of metal detector gates on implanted permanent pacemakers. Pacing Clin Electrophysiol 1988; 11(10): 1386-7.
42) Butrous GS, Bexton RS, Barton DG, Male JC, Camm AJ. Interference with the pacemakers of two workers at electricity substations. Br J Ind Med 1983; 40(4): 462-5.
43) Kaye GC, Butrous GS, Allen A, Meldrum SJ, Male JC, Camm AJ. The effect of 50 Hz external electrical interference on implanted cardiac pacemakers. Pacing Clin Electrtophysiol 1988; 11(7): 999-1008.
44) Astridge PS, Kaye GC, Whitworth S, Kelly P, Camm AJ, Perrins EJ. The response of implanted dual chamber pacemakers to 50 Hz extraneous electrical interference. Pacing Clin Electrophysiol 1993; 16(10): 1966-74.
45) Mehdirad A, Love C, Nelson S, Schaal S, Collins J, Huffman K. Alternating current electrocution detection and termination by an implantable cardioverter-defibrillator. Pacing Clin Electrophysiol 1997; 20(7): 1885-6.
46) Marco D, Eisinger G, Hayes DL. Testing of work environments for electromagnetic interference. Pacing Clin Electrophysiol 1992; 15(11 Pt 2): 2016-22.
47) Gurevitz O, Fogel RI, Herner M. Patients with ICDs can return to the industrial workplace: a simple-screening protocol predicts long term after safety. Pacing Clin Electrophysiol 2001; 24:612. (Abstract).
48) Man KC, Davidson T, Lanberg JJ, Morady F, Kalbfleisch SJ. Interference from a hand held radiofrequency remote control causing discharge of an implantable defibrillator. Pacing Clin Electrophysiol 1993; 16(8): 1756-8.
49) Seifert T, Block M, Borggrefe M, Breithardt G. Erroneous discharge of an implantable cardioverter-defibrillator caused by an electric razor. Pacing Clin Electrophysiol 1995; 18(8): 1592-4.
50) Manolis AG, Katsivas AG, Vassilopoulos CV, Louvros NE. Implantable cardioverter defibrillator: an unusual case of inappropriate discharge during showering. J Interv Card Electrophysiol 2000; 4(1):265-8.
51) Madrid A, Sánchez A, Bosch E, Fernández E, Moro Serrano C. Dysfunction of implantable defibrillators caused by slot machines. Pacing Clin Electrophysiol 1997; 20(1 Pt 2): 212-4.
52) Duru F, Luechinger R, Scheidegger MB, Luscher TF, Boesiger P, Candinas R. Pacing and magnetic resonance imaging environment: Clinical and technical considerations on compatibility. Eur Heart J 2001; 22(2): 113-24.
53) Vahlhaus C, Sommer T, Lewalter T, Schimpf R, Schumacher B, Jung W, et al. Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 Tesla?Pacing Clin Electrophysiol 2001; 24(4 Pt 1): 489-95.
54) von Smeakal A, Wolke S, Seelos KC. Cardiac pacemakers in magnetic resonance studies: influence of the static magnetic field on hardware components and software. Eur Heart J 1993; 14(Suppl.): 335. (Abstract).
55) Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrrophysiol 2001; 24(2): 199-205.
56) Shellock FG, Morisoli SM. Ex vivo evaluation of ferromagnetism and artifacts of cardiac occluders exposed to a 1.5-T MR system. J Magn Reson Imaging 1994; 4(2): 213-5.
57) Lauck G, von Smekal A, Wolke S, Seelos KC, Jung W, Manz M, et al. Effects of nuclear magnetism resonance imaging on cardiac pacemakers. Pacing Clin Electrophysiol 1995; 18(8): 1549-55.
58) Hayes DL, Holmes DR Jr, Gray JE. Effect of 1.5 tesla nuclear magnetic resonance scanner on implanted permanent pacemakers. J Am Coll Cardiol 1987; 10(4): 782-6.
59) Fontaine JM, Mohamed FB, Gottlieb C, Callans DJ, Marchlinski FE. Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol 1998; 21(6): 1336-9.
60) Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997; 134(3): 467-73.
61) Luechinger R, Duru F, Scheidegger M. Heating effects of magnetic resonance imaging on pacemaker leads: Effects of lead types, lead positioning and reproductibility of findings. Pacing Clin Electrophysiol 1999; 22: 717. (Abstract).
62) Luechinger R, Duru F, Scheidegger M. Heating effects of magnetic resonance imaging of the brain on pacemaker leads: send/receive coils versus receive-only coil. J Am Coll Cardiol 2001; 37(Suppl. A): 436A. (Abstract).
63) Sommer T, Vahlhaus C, Lauch G, von Smekal A, Reinke M, Hofer U, et al. MR imaging and cardiac pacemakers: in vitro evaluation and in vivo studies in 51 patients at 0.5 T. Radiology 2000; 215(3): 869-79.
64) de Cock CC , Spruijt HJ, van Campen LM , Plu AW, Visser CA. Electromagnetic interference of an implantable loop recorder by commonly encountered electronic devices. Pacing Clin Electrophysiol 2000; 23(10 Pt 1): 1516-8.
65) Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent pacemakers. Pacing Clin Electrophysiol 1996; 19(6): 913-9.
66) Coman JA Jr, Martin ET, Ramza BM, et al. Pacemaker safett during magnetic resonance imaging at 1.5 tesla. (abstract) J Am Coll Cardiol 2001; 37(Suppl.A): 436A.
67) Andersen C, Oxhoj H, Arnsbo P. Management of spinal cord stimulators in patients with cardiac pacemakers. Pacing Clin Electrophysiol 1990; 13(5): 574-7.
68) Monahan K, Casavant D, Rasmussen C, Hallet N. Combined use of a true-bipolar sensing implantable cardioverter defibrillator in a patient having a prior implantable spinal cord stimulator for intractable pain. Pacing Clin Electrophysiol 1998; 21(12): 2669-72.
69) Romano M, Zucco F, Baldini MR, Allaria B. Technical and clinical problems in patients with simultaneous implantation of a cardiac pacemaker and a spinal cord stimulator. Pacing Clin Electrophysiol 1993; 16(8): 1639-44.
70) Tavernier R, Fonteyne W, Vandewalle V, de Sutter J , Gevaert S. Use of an implantable cardioverter defibrillator in a patient with two implanted neurostimulators for severe Parkinson’s disease. Pacing Clin Electrophysiol 2000; 23(6): 1057-9.
71) Obwegeser AA, Uitti RJ, Turk MF, Wszolek UM, Flipse TR, Smallridge RC, et al. Simultaneous thalamic deep brain stimulation and implantable cardioverter-defibrillator. Mayo Clin Proc 2001; 76(1): 87-9.
72) Kleinpell R, Bedrosian C, McCormick L, Kremer M, Bujalski L, Bronsted R. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU. Am J Crit Care 1996; 5(6): 449-54.
73) O’Flaherty D, Wardill M, Adams AP. Inadvertent suppression of a fixed rate ventricular pacemaker using a peripheral nerve stimulator. Anaesthesia 1993; 48(8): 687-9.
74) LaBan MM, Petty D, Hauser AM, Taylor RS. Peripheral nerve conduction stimulation: it’s effect on cardiac pacemakers. Arch Phys Med Rehabil 1988; 69(5):358-62.
75) Eriksson M, Schuller H, Sjolund B. Hazard from transcutaneous nerve stimulation in patients with pacemakers. Lancet 1978; 1(8077): 1319.
76) Chen D, Philip M, Philip PA, Monga TN. Cardiac pacemaker inhibition by transcutaneous electrical nerve stimulation. Arch Phys Med Rehabil 1990; 71(1): 27-30.
77) Rasmussen MJ, Hayes DL, Vlietstra RE, Thorsteinsson G. Can transcutaneous electrical nerve stimulation be safely used in patients with permanent cardiac pacemakers?Mayo Clin Proc 1988; 63(5): 443-5.
78) Glotzer TV, Gordon M, Sparta M, Radoslovich G, Zimmerman J. Electromagnetic interference from a muscle stimulation device causing discharge of an implantable cardioverter defibrillator: epicardial bipolar and endocardial bipolar sensing circuits are compared. Pacing Clin Electrophysiol 1998; 21(10): 1996-8.
79) LeVasseur JG, Kennard CD, Finley EM, Muse RK. Dermatologic electrosurgery in patients with implantable cardioverter-defibrillators and pacemakers. Dermatol Surg 1998; 24(2): 233-40.
80) Batra YK, Bali IM. Effect of coagulating and cutting current on a demand pacemaker during transurethral resection of the prostate: a case report. Can Anaesth Soc J 1978; 25(1): 65-6.
81) Gruber M, Seebald C, Byrd R, Tomasulo V, Mahl T. Electrocautery and patients with implanted cardiac devices. Gastroenterol Nurs 1995; 18(2): 49-53.
82) Ahern TS, Luckett C, Ehrlich S, et al. Use of bipolar electrocautery in patients with implantable cardioverter-defibrillators: no reason to inactivate detections or therapies. Pacing Clin Electrophysiol 1999; 22: 778. (Abstract).
83) Erdman S, Levinsky L, Strasberg B, Agmon J, Levy MJ. Use of the Shaw Scalpel in pacemaker operations. J Thorac Cardiovasc Surg 1985; 89(2): 304-7.
84) Kott I, Watemberg S, Landau O, Avrahami R, Kaplan I, Giler S. The use of CO2 laser for inguinal hernia repair in elderly, pacemakers wearers. J Clin Laser Med Surg 1995; 13(5):335-6.
85) Lloyd Jones S, Mason RA. Laser surgery in a patient with Romano-Ward (long QT) syndrome and an automatic implantable cardioverter defibrillator. Anaesthesia 2000; 55(4): 362-6.
86) Epstein MR, Mayer JEJr, Duncan BW. Use of an ultrasonic scalpel as an alternative to electrocautery in patients with pacemakers. Ann Thorac Surg 1998; 65(6): 1802-4.
87) Rasmussen MJ, Rea RF, Tri JL, Larson TR, Hayes DL. Use of a transurethral microwave thermotherapeutic device with permanent pacemakers and implantable defibrillators. Mayo Clin Proc 2001; 76(6): 601-3.
88) Van Hemel NM, Hamerlijnck RP, Pronk KJ, Van der Veen EP. Upper limit ventricular stimulation in respiratory rate responsive pacing due to electrocautery. Pacing Clin Electrophysiol 1989; 12(11):1720-3.
89) Wong DT, Middleton W. Electrocautery induced tachycardia in rate-responsive pacemaker. Anesthesiology 2001; 94(4): 710-1.
90) Levine PA, Balady GJ, Lazar HL, Belott PH, Roberts AJ. Electrocautery and pacemakers: management of the paced patient subject to electrocautery. Ann Thorac Surg 1986; 41(3): 313-7.
91) Román-González J, Hyberger LK, Hayes DL. IS electrocautery still a clinically significant problem with contemporary technology?Pacing Clin Electrophysiol 2001; 24: 709. (Abstract).
92) Lamas GA, Antman EM, Gold JP, Braunwald NS, Collins JJ. Pacemaker backup-mode reversion and injury during cardiac surgery. Ann Thorac Surg 1986; 41(2): 155-7.
93) Geddes LA, Tacker WA, Cabler O. A new electrical hazard associated with the electrocautery. Med Instrum 1975; 9(2): 112-3.
94) Heller LI. Surgical electrocautery and the runaway pacemaker syndrome. Pacing Clin Electrophysiol 1990; 13(9): 1084-5.
95) Moran MD, Kirchhoffer JB, Cassaver DK, Green HL. Electromagnetic interference (EMI) caused by electrocautery during surgical procedures. Pacing Clin Electrophysiol 1996; 19(6): 1009. (Letter).
96) Peters RW, Gold MR. Reversible prolonged pacemaker failure due to electrocautery. J Interv Card Electrophysiol 1998; 2(4):3 43-4.
97) Nercessian OA, Wu H, Nazarian D, Mahmud F. Intraoperative pacemaker dysfunction caused by the use of electrocautery during a total hip arthoplasty. J Arthroplasty 1998; 13(5): 599-602.
98) Strathmore NF. Interference in cardiac pacemakers. In: Ellenbogen KA, Kay GN, Wilkoff BL, eds. Clinical cardiac pacing. Philadelphia: W.B. Saunders, 1995: 770-9.
99) Goldschlager N, Epstein A, Friedman P, Gang E, Krol R, Olshansky B. North American Society of Pacing and Electrophysiology (NASPE). Practice Guideline Committee. Environmental and drug effects on patients with implantable cardioverter/defibrillators: a practical guide to patient treatment. Arch Intern Med 2001; 161(5): 649-55.
100) Domino KB, Smith TC. Electrocautery-induced reprogramming of a pacemaker using a precordial magnet. Anesth Analg 1983; 62(6): 609-12.
101) El-Gamal HM, Dufresne RG, Saddler K. Electrosurgery, pacemakers and ICDs: a survey of precautions and complications experienced by cutaneous surgeons. Dermatol Surg 2001; 27(4): 385-90.
102) Aylward P, Blood R, Tonkin A. Complications of defibrillation with permanent pacemaker in situ. Pacing Clin Electrophysiol 1979; 2(4): 462-4.
103) Levine PA, Barold SS, Fletcher RD, Talbot P. Advese acute and chronic effects of electrical defibrillation and cardioversion on implanted unipolar pacing systems. J Am Coll Cardiol 1983; 1(6): 1413-22.
104) Das G, Staffanson DB. Selective dysfunction of ventricular electrode-endocardial junction following DC cardioversion in a patient with a dual chamber pacemaker. Pacing Clin Electrophysiol 1997; 20(2 Pt 1): 364-5.
105) Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D. Tchou PJ, et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000; 101(11): 1282-7.
106) Bardy GH, Marchlinski FE, Sharma AD, Worley SJ, Luceri RM, Yee R, et al. Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Transthoracic Investigators. Circulation 1996; 94(10):2507-14.
107) Prakash A, Saksena S, Mathew P, Krol RB. Internal atrial defibrillation: effect on sinus and atrioventricular nodal function and implanted cardiac pacemakers. Pacing Clin Electrophysiol 1997; 20(10 Pt 1): 2434-41.
108) Vanerio G, Maloney J, Rashidi R, McCowan R, Castle L, Morant V, et al. The effects of percutaneous catheter ablation on preexisting permanent pacemakers. Pacing Clin Electrophysiol 1990; 13(12 Pt 1): 1637-45.
109) Strickberger SA, Man KC, Daoud EG, Goyal R, Brinkman K, Hasse C, et al. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary arthery disease and an implantable cardioverter-defibrillator. Circulation 1997; 96(5): 1525-31.
110) Trohman RG, Simmons TW, Moore SL, Firstenberg MS, Williams D, Maloney JD. Catheter ablation of the atrioventricular junction using radiofrequency energy and a bilateral cardiac approach. Am J Cardiol 1992; 70(18): 1438-43.
111) Chin MC, Rosenqvist M, Lee MA, Griffin JC, Langberg JJ. The effect of radiofrequency catheter ablation on permanent pacemakers: an experimental study. Pacing Clin Electrophysiol 1990; 13(1): 23-9.
112) Dick AJ, Jones DL, Klein GJ. Effects of RF energy delivery to pacing and defibrillation leads. Pacing Clin Electrophysiol 2001; 24: 658. (Abstract).
113) Ellenbogen KA, Wood MA, Stambler BS. Acute effects of radiofrequency ablation on atrial arrhythmias on implanted permanent pacing systems. Pacing Clin Electrophysiol 1996; 19(9): 1287-95.
114) Chang AC, McAreavey D, Tripodi D, Fananapazir L. Radiofrequency catheter atrioventricular node ablation in patients with permanent cardiac pacing systems. Pacing Clin Electrophysiol 1994; 17(1): 65-9.
115) Pfeiffer D, Tebbenjohanns J, Schumacher B, Jung W, Luderitz B. Pacemaker function during radiofrequency ablation. Pacing Clin Electrophysiol 1995; 18(5 Pt 1): 1037-44.
116) Sadoul N, Blankoff I, de Chillou C, Beurrier D, Messier M, Bizeau O, et al. Effects of radiofrequency catheter ablation on patients with permanent pacemakers. J Interv Card Electrophysiol 1997; 1(3): 227-33.
117) Proclemer A, Facchin D, Pagnutti C, Fioretti P, De Michele C . Safety of pacemaker implantion prior to radiofrequency ablation of atrioventricular junction in a single session procedure. Pacing Clin Electrophysiol 2000; 23(6): 998-1002.
118) Wolfe DA, McCutcheon MJ, Plumb VJ, et al. Radiofrequency current may induce exit block in chronically implanted ventricular leads. Pacing Clin Electrophysiol 1995; 18: 9199. (Abstract).
119) Burke MC, Kopp DE, Alberts M. Effect of radiofrequency current on previously implanted pacemaker and defibrillator ventricular lead systems. Pacing Clin Electrophysiol 2000; 23: 659. (Abstract).
120) van Gelder BM, Bracke FA, el Gamal MI. Upper rate pacing after radiofrequency catheter ablation in a minute ventilation rate adaptive DDD pacemaker. Pacing Clin Electrophysiol 1994; 17(8): 1437-40.
121) Chow GK, Streem SB. Extracorporeal lithotrispy. Update on technology. Urol Clin North Am 2000; 27(2): 315-22.
122) Langberg J, Abber J, Thuroff JW, Griffin JC. The effects of extracorporeal shock wave lithotrispy on a pacemaker function. Pacing Clin Electrophysiol 1987; 10(5): 1142-6.
123) Fetter J, Patterson D, Aram G, Hayes DL. Effects of extracorporeal shock wave lithotrispy on a single chamber rate response and dual chamber pacemakers. Pacing Clin Electrophysiol 1989; 12(9): 1494:501.
124) Cooper D, Wilkoff B, Masterson M, Castle L, Belco K, Simmons T, et al. Effects of extracorporeal shocks wave lithotripsy on cardiac pacemakers and its safety in patients with implanted cardiac pacemakers. Pacing Clin Electrophysiol 1988; 11(11 Pt 1): 1607-16.
125) Vassolas G, Roth RA, Venditti FJJr. Effect of extracorporeal shock wave lithotripsy on implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1993; 16(6): 1245-8.
126) Kufer R, Thamasett S, Volkmer B, Hautmann RE, Gschwend JE. New-generation lithotripters for treatment of patients with implantable cardioverter-defibrillator: experimental approach and review of the literature. J Endourol 2001; 15(5): 479-84.
127) Drach GW, Weber C, Donovan JM. Treatment of pacemaker with extracorporeal shock wave lithotripsy: experience from 2 continents. J Urol 1990; 143(5): 895-6.
128) Albers DD, Lybrand FE 3rd, Axton JC, Wendelken JR. Shockwave lithotripsy and pacemakers: experience with 20 cases. J Endourol 1995; 9(4): 301-3.
129) Venditti FJ Jr, Martin D, Long AL, Roth RA. Renal extracorporeal shock wave lithotripsy performed in patient with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1991; 14(9): 1323-5.
130) Chung MK, Streem, SB, Ching E, Grooms M, Mowrey KA, Wilkoff BL. Effects of extracorporeal shock wave lithotripsy on tiered therapy implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1999; 22(5): 738-42.
131) Streem SB. Contemporary clinical practice of shock wave lithotripsy: a reevaluation of contraindications. J Urol 1997; 157(4): 1197-203.
132) Venselaar JL. The effects of ionizing radiation on eight cardiac pacemakers and the influence of electromagnetic interference from two linear accelerators. Radiother Oncol 1985; 3(1): 81-7.
133) Marbach JR, Meoz-Méndez RT, Huffman JK, Hudgins PT, Almond PR. The effects of cardiac pacemakers of ionizing radiation and electromagnetic interference from radiotherapy machines. Int J Radiat Oncol Biol Phys 1978; 4(11-12): 1055-8.
134) Souliman SK, Christie J. Pacemaker failure induced by radiotherapy. Pacing Clin Electrophysiol 1994; 17(3 Pt 1): 270-3.
135) Katzenberg CA, Marcus FI, Heusinkveld RS, Mammana RB. Pacemaker failure due to radiation therapy. Pacing Clin Electrophysiol 1982; 5(2): 156-9.
136) Last A. Radiotherapy in patients with cardiac pacemakers. Br J Radiol 1998; 71(841): 4-10.
137) Rodríguez F, Filimonov A, Henning A, Coughlin C, Greenberg M. Radiation-induced effects in multiprogramma-ble pacemakers and implantable defibrillators. Pacing Clin Electrophysiol 1991; 14(12): 2143-53.
138) Marbach JR, Sontag MR, Van Dyk J, Wolbarst AB. Management of radiation oncology patients with implanted cardiac pacemakers: report of AAPM Task Group Nº 34. American Association of Physicists in Medicine. Med Phys 1994; 21(1): 85-90.
Publicado
2004-08-31
Cómo citar
1.
Fernández Banizi P, Vidal L, Montenegro JL, Banina Aguerre D, Vanerio G, Antunes S, Fiandra D, Fiandra HA, Lupano D, Fiandra O. Interferencias electromagnéticas en pacientes con marcapasos y cardiodesfibriladores implantados. Rev. Méd. Urug. [Internet]. 31 de agosto de 2004 [citado 12 de mayo de 2024];20(2):150-6. Disponible en: http://www2.rmu.org.uy/ojsrmu311/index.php/rmu/article/view/921
Sección
Trabajos de Revisión o Actualización y Puestas al día